Type I IFN inhibits innate IL-10 production in macrophages through histone deacetylase 11 by downregulating microRNA-145

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3896-3904

  Lin, Li ^a,b   Hou, Jin ^c   Ma, Feng ^b   Wang, Pin ^c   Liu, Xingguang ^c   Li, Nan ^c   Wang, Jianli ^b   Wang, Qingqing ^b   Cao, Xuetao ^a,b,c  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 11; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 10; JANUS KINASE 1; MICRORNA 143; MICRORNA 145; STAT1 PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IL10 GENE; INNATE IMMUNITY; MACROPHAGE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASES; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; INTERLEUKIN-10; INTERLEUKIN-12; JANUS KINASE 1; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICRORNAS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC;

EID: 84885143064     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203450     Document Type: Article

References (47)

1. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
2. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10:170-181.
3. Chang, E. Y., B. Guo, S. E. Doyle, and G. Cheng. 2007. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharideinduced IL-10 production. J. Immunol. 178:6705-6709.
4. Pattison, M. J., K. F. Mackenzie, and J. S. Arthur. 2012. Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback. J. Immunol. 189:2784-2792.
5. Lang, R., D. Patel, J. J. Morris, R. L. Rutschman, and P. J. Murray. 2002. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169:2253-2263.
6. Hammer, M., J. Mages, H. Dietrich, F. Schmitz, F. Striebel, P. J. Murray, H. Wagner, and R. Lang. 2005. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur. J. Immunol. 35:2991-3001.
7. Gao, L., M. A. Cueto, F. Asselbergs, and P. Atadja. 2002. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277:25748-25755.
8. Villagra, A., F. Cheng, H. W. Wang, I. Suarez, M. Glozak, M. Maurin, D. Nguyen, K. L. Wright, P. W. Atadja, K. Bhalla, et al. 2009. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat. Immunol. 10:92-100.
9. Bushati, N., and S. M. Cohen. 2007. microRNA functions. Annu. Rev. Cell Dev. Biol. 23:175-205.
10. Calin, G. A., and C. M. Croce. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6:857-866.
11. O'Neill, L. A., F. J. Sheedy, and C. E. McCoy. 2011. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11:163-175.
12. Xiao, C., and K. Rajewsky. 2009. MicroRNA control in the immune system: basic principles. Cell 136:26-36.
13. O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10:111-122.
14. Ma, F., S. Xu, X. Liu, Q. Zhang, X. Xu, M. Liu, M. Hua, N. Li, H. Yao, and X. Cao. 2011. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-g. Nat. Immunol. 12:861-869.
15. Rottiers, V., and A. M. Näär. 2012. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 13:239-250.
16. Kent, O. A., R. R. Chivukula, M. Mullendore, E. A. Wentzel, G. Feldmann, K. H. Lee, S. Liu, S. D. Leach, A. Maitra, and J. T. Mendell. 2010. Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feedforward pathway. Genes Dev. 24:2754-2759.
17. Zhang, J., Q. Sun, Z. Zhang, S. Ge, Z. G. Han, and W. T. Chen. 2013. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 32:61-69.
18. Cordes, K. R., N. T. Sheehy, M. P. White, E. C. Berry, S. U. Morton, A. N. Muth, T. H. Lee, J. M. Miano, K. N. Ivey, and D. Srivastava. 2009. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460:705-710.
19. Xin, M., E. M. Small, L. B. Sutherland, X. Qi, J. McAnally, C. F. Plato, J. A. Richardson, R. Bassel-Duby, and E. N. Olson. 2009. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23:2166-2178.
20. Boettger, T., N. Beetz, S. Kostin, J. Schneider, M. Krüger, L. Hein, and T. Braun. 2009. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 119:2634-2647.
21. Jordan, S. D., M. Krüger, D. M. Willmes, N. Redemann, F. T. Wunderlich, H. S. Brönneke, C. Merkwirth, H. Kashkar, V. M. Olkkonen, T. Böttger, et al. 2011. Obesity-induced overexpression of miRNA-143 inhibits insulinstimulated AKT activation and impairs glucose metabolism. Nat. Cell Biol. 13:434-446.
22. Fang, R., T. Xiao, Z. Fang, Y. Sun, F. Li, Y. Gao, Y. Feng, L. Li, Y. Wang, X. Liu, et al. 2012. MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J. Biol. Chem. 287:23227-23235.
23. Collison, A., J. Mattes, M. Plank, and P. S. Foster. 2011. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J. Allergy Clin. Immunol. 128:160-167, e4.
24. Hou, J., P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183:2150-2158.
25. Wang, P., J. Hou, L. Lin, C. Wang, X. Liu, D. Li, F. Ma, Z. Wang, and X. Cao. 2010. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J. Immunol. 185:6226-6233.
26. Ma, F., X. Liu, D. Li, P. Wang, N. Li, L. Lu, and X. Cao. 2010. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J. Immunol. 184:6053-6059.
27. Liu, X., Z. Zhan, D. Li, L. Xu, F. Ma, P. Zhang, H. Yao, and X. Cao. 2011. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat. Immunol. 12:416-424.
28. Xu, S., X. Liu, Y. Bao, X. Zhu, C. Han, P. Zhang, X. Zhang, W. Li, and X. Cao. 2012. Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway. Nat. Immunol. 13:551-559.
29. Kaiser, F., D. Cook, S. Papoutsopoulou, R. Rajsbaum, X. Wu, H. T. Yang, S. Grant, P. Ricciardi-Castagnoli, P. N. Tsichlis, S. C. Ley, and A. O'Garra. 2009. TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells. J. Exp. Med. 206:1863-1871.
30. -/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176:5788-5796.
31. Ma, W., W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar. 2001. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276:13664-13674.
32. Kim, C., Y. Sano, K. Todorova, B. A. Carlson, L. Arpa, A. Celada, T. Lawrence, K. Otsu, J. L. Brissette, J. S. Arthur, and J. M. Park. 2008. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro-and anti-inflammatory gene expression. Nat. Immunol. 9:1019-1027.
33. Saraiva, M., J. R. Christensen, A. V. Tsytsykova, A. E. Goldfeld, S. C. Ley, D. Kioussis, and A. O'Garra. 2005. Identification of a macrophage-specific chromatin signature in the IL-10 locus. J. Immunol. 175:1041-1046.
34. Hu, X., P. K. Paik, J. Chen, A. Yarilina, L. Kockeritz, T. T. Lu, J. R. Woodgett, and L. B. Ivashkiv. 2006. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24:563-574.
35. Yee, C. S., Y. Yao, Q. Xu, B. McCarthy, D. Sun-Lin, M. Tone, H. Waldmann, and C. H. Chang. 2005. Enhanced production of IL-10 by dendritic cells deficient in CIITA. J. Immunol. 174:1222-1229.
36. Van Deusen, J. B., M. H. Shah, B. Becknell, B. W. Blaser, A. K. Ferketich, G. J. Nuovo, B. M. Ahmer, J. Durbin, and M. A. Caligiuri. 2006. STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. Eur. J. Immunol. 36:623-630.
37. Riemann, M., R. Endres, S. Liptay, K. Pfeffer, and R. M. Schmid. 2005. The IkappaB protein Bcl-3 negatively regulates transcription of the IL-10 gene in macrophages. J. Immunol. 175:3560-3568.
38. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature 390:350-351.
39. Chung, E. Y., J. Liu, Y. Homma, Y. Zhang, A. Brendolan, M. Saggese, J. Han, R. Silverstein, L. Selleri, and X. Ma. 2007. Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 27:952-964.
40. Zhang, M., S. Xu, Y. Han, and X. Cao. 2011. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membranebound TGF-b. Hepatology 53:306-316.
41. Haberland, M., R. L. Montgomery, and E. N. Olson. 2009. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10:32-42.
42. Selbach, M., B. Schwanhäusser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455:58-63.
43. Borden, E. C., G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff, G. R. Foster, and G. R. Stark. 2007. Interferons at age 50:past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6:975-990.
44. González-Navajas, J. M., J. Lee, M. David, and E. Raz. 2012. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12:125-135.
45. Billiau, A. 2006. Anti-inflammatory properties of Type I interferons. Antiviral Res. 71:108-116.
46. Ziegler-Heitbrock, L., M. Lötzerich, A. Schaefer, T. Werner, M. Frankenberger, and E. Benkhart. 2003. IFN-a induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J. Immunol. 171:285-290.
47. Wang, H., J. Brown, C. A. Garcia, Y. Tang, M. R. Benakanakere, T. Greenway, P. Alard, D. F. Kinane, and M. Martin. 2011. The role of glycogen synthase kinase 3 in regulating IFN-b-mediated IL-10 production. J. Immunol. 186:675-684.